Condition
Symptomatic Parkinson Disease
Total Trials
4
Recruiting
0
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 2 (4)
Trial Status
Active Not Recruiting4
Clinical Trials (4)
Showing 4 of 4 trials
NCT04218968Phase 2Active Not Recruiting
Cardiac Changes in Early Parkinson's Disease: A Follow up Study
NCT05109364Phase 2Active Not RecruitingPrimary
Terazosin and Parkinson's Disease Extension Study
NCT03775096Phase 2Active Not Recruiting
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
NCT04386317Phase 2Active Not Recruiting
Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
Showing all 4 trials